Finally, the small molecule inhibitor JQ1 blocked recruitment of Brd2 to AR–regulated genes, prevented transcriptional activation of these genes, and inhibited prostate cancer cell proliferation. This evidence concerns the gene BRD2 and prostate carcinoma.